Pregabalin or morphine and gabapentin for neuropathic pain

被引:8
作者
Doggrell, SA [1 ]
机构
[1] Univ Auckland, Div Hlth Practice, Auckland 1, New Zealand
关键词
gabapentin; morphine; neuropathic pain; pregabalin;
D O I
10.1517/14656566.6.14.2535
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Common causes of neuropathic pain are diabetes and herpes zoster, with 15% of patients with long-standing diabetes and 11% of herpes patients suffering from this pain. Gabapentin and pregabalin modulate the alpha(2)delta calcium-channel subunits, possibly decreasing the neurotransmitter release associated with the central sensitisation that occurs in neuropathic pain. Gabapentin has been shown to be effective in neuropathic pain and, recently, so has pregabalin. These agents seem to have similar efficacy when used alone, but this needs to be tested in a head-to-head trial. A clinical trial comparing morphine, gabapentin or their combination at lower doses showed that the combination of morphine and gabapentin reduced the pain score to a greater extent than either agent alone. This combination treatment represents a novel approach to neuropathic pain.
引用
收藏
页码:2535 / 2539
页数:5
相关论文
共 11 条
  • [1] Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial
    Backonja, M
    Beydoun, A
    Edwards, KR
    Schwartz, SL
    Fonseca, V
    Hes, M
    LaMoreaux, L
    Garofalo, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21): : 1831 - 1836
  • [2] Pregabalin pharmacology and its relevance to clinical practice
    Ben-Menachem, E
    [J]. EPILEPSIA, 2004, 45 : 13 - 18
  • [3] Contemporary management of neuropathic pain for the primary care physician
    Chen, HP
    Lamer, TJ
    Rho, RH
    Marshall, KA
    Sitzman, BT
    Ghazi, SM
    Brewer, RP
    [J]. MAYO CLINIC PROCEEDINGS, 2004, 79 (12) : 1533 - 1545
  • [4] XP13512 [(±)-1-([(α-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug:: II.: Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys
    Cundy, KC
    Annamalai, T
    Bu, L
    De Vera, J
    Estrela, J
    Luo, W
    Shirsat, P
    Torneros, A
    Yao, FM
    Zou, J
    Barrett, RW
    Gallop, MA
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 311 (01) : 324 - 333
  • [5] Pregabalin for the treatment of postherpetic neuralgia - A randomized, placebo-controlled trial
    Dworkin, RH
    Corbin, AE
    Young, JP
    Sharma, U
    LaMoreaux, L
    Bockbrader, H
    Garofalo, EA
    Poole, RM
    [J]. NEUROLOGY, 2003, 60 (08) : 1274 - 1283
  • [6] Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens
    Freynhagen, R
    Strojek, K
    Griesing, T
    Whalen, E
    Balkenohl, M
    [J]. PAIN, 2005, 115 (03) : 254 - 263
  • [7] Morphine, gabapentin, or their combination for neuropathic pain
    Gilron, I
    Bailey, JM
    Tu, DS
    Holden, RR
    Weaver, DF
    Houlden, RL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13) : 1324 - 1334
  • [8] Pregabalin relieves symptoms of painful diabetic neuropathy - A randomized controlled trial
    Lesser, H
    Sharma, U
    LaMoreaux, L
    Poole, RM
    [J]. NEUROLOGY, 2004, 63 (11) : 2104 - 2110
  • [9] Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trial
    Richter, RW
    Portenoy, R
    Sharma, U
    Lamoreaux, L
    Bockbrader, H
    Knapp, LE
    [J]. JOURNAL OF PAIN, 2005, 6 (04) : 253 - 260
  • [10] Gabapentin for the treatment of postherpetic neuralgia - A randomized controlled trial
    Rowbotham, M
    Harden, N
    Stacey, B
    Bernstein, P
    Magnus-Miller, L
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21): : 1837 - 1842